Lakeside(NASDAQ) LSH

Lakeside helps companies move goods between the U.S. China, and South Korea. Its services include shipping, customs, and warehousing for e-commerce and manufacturers. The company also distributes medical products in China, supporting healthcare supply chains.

Moving the World: Products and Services

• Cross-border airfreight: Ships goods by air between Asia and the U.S; 54.7% of revenue for the nine months ended March 31, 2025.
• Cross-border ocean freight: Moves cargo by sea for global clients; 39.1% of revenue.
• Pharmaceutical distribution: Supplies medical products in China; 6.2% of revenue.
• Freight consolidation and forwarding: Combines shipments for efficiency; serves logistics firms and manufacturers.
• Customs clearance: Handles import/export paperwork for clients in multiple countries.
• Warehousing and ground transport: Stores and delivers goods within the U.S. for e-commerce and industry.

Growth and Expansion: The Road So Far

• Acquired Hupan Pharmaceutical (Hubei) in November 2024, entering China’s medical supply market.
• Completed IPO in July 2024, raising $5.35 million for operations and growth.
• Issued convertible notes and warrants in March-April 2025 to boost capital resources.
• Expanded U.S. warehousing footprint in Illinois and Texas, now totaling 142,484 square feet.
• Plans to sublease excess warehouse space in Chicago to manage costs.

What Makes Lakeside Stand Out

Lakeside connects Asia and the U.S. with integrated logistics, using large regional warehouses and a broad carrier network. Its bundled services help e-commerce and manufacturers streamline cross-border trade. The company’s recent move into pharmaceutical distribution diversifies its revenue and client base.

Five Things You Need to Know

• Revenue was $11.48 million for nine months ended March 2025, down 15.1% year-on-year.
• Gross margin fell to 10.4% in March 2025, from 19.9% the previous year.
• Net loss reached $4.35 million for nine months ended March 2025, up from $0.23 million loss prior year.
• Cross-border airfreight and ocean freight made up 93.8% of revenue in March 2025.
• Working capital deficit was $1.7 million as of March 2025, with a current ratio of 0.73:1.

Bottom Line

Lakeside has expanded from logistics into medical supply distribution, adapting to shifting markets. The company faces financial and operational challenges but continues to diversify its business model.